Styrenix Performance Materials Ltd Q3 FY25 Results & Concall Highlights: Revenue, Margins & Order Book

Published 4 Aug 2026 | Chemicals & Petrochemicals | Market Cap: ₹3.8K Cr

India business volume growth guidance maintained at 15% to 20%, driven by capacity debottlenecking and expansions. Styrenix expects volume growth guidance of 15% to 20% for the India business, driven by capacity expansion and debottlenecking efforts. - Polystyrene capacity has expanded from 65,000 to 100,000 tonnes; further debottlenecking and capacity increase up to 150,000 tonnes are planned, expected to yield good ROCE despite lower polystyrene margins. - ABS expansion is planned in phases, adding 50,000 tonnes per phase; overall investment of approximately Rs.

From Styrenix Performance Materials Ltd's Q3 FY25 earnings-call transcript · updated 23 Aug 2026.

Price

2,082

Market Cap

₹3.8K Cr

P/E Ratio

14.0

How does Styrenix Performance Materials Ltd rank in Chemicals & Petrochemicals?

Compare Styrenix Performance Materials Ltd against every Chemicals & Petrochemicals company this quarter on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Styrenix Performance Materials Ltd — Quarterly revenue & net profit

Revenue Net Profit
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹826 Cr, net profit ₹73 Cr.

Full financials →

📊 Revenue & Sales Performance

  • India business volume growth guidance maintained at 15% to 20%, driven by capacity debottlenecking and expansions.
  • Additional capacities in India (ABS and polystyrene) are being debottlenecked and expanded, enabling higher sales volumes.
  • Thailand business presents significant growth opportunity with only 10%-12% market share currently; market size is larger than India’s.
  • Thailand plant can increase volumes by tapping into underutilized sectors (automotive, household) not currently served in India.
  • Thailand revenue growth expected to follow India’s trend as capacity utilization improves.
  • Synergies between India and Thailand operations, including exports to multiple Asian markets (China, Hong Kong, Japan, Korea, Indonesia, Vietnam).
  • Additional working capital may be needed as business grows; no major CAPEX planned currently for Thailand.
  • Full utilization of expanded capacities in India and Thailand expected to increase revenues and improve profitability over time.

📈 Profitability & Margins

  • Styrenix expects volume growth guidance of 15% to 20% for the India business, driven by capacity expansion and debottlenecking efforts.
  • Polystyrene capacity has expanded from 65,000 to 100,000 tonnes; further debottlenecking and capacity increase up to 150,000 tonnes are planned, expected to yield good ROCE despite lower polystyrene margins.
  • ABS expansion is planned in phases, adding 50,000 tonnes per phase; overall investment of approximately Rs. 500 crores envisioned for ABS/SAN expansions.
  • Thailand operations are expected to improve profitability with volume growth, leveraging synergies from technology upgrades and new product profiles.
  • Operating leverage benefits are anticipated as capacity utilization improves, with ongoing cost-saving initiatives (e.g., fuel savings in Dahej plant).
  • Management expects spread levels to remain healthy, supporting earnings growth going forward.
  • No major CAPEX planned immediately for Thailand; additional working capital may be required as business grows.

🏗️ Capital Expenditure Plans

  • Polystyrene expansion: Debottlenecking increased capacity from 65,000 to 100,000 tonnes, adding about 35,000 tonnes volume at Rs. 16 crores capex with good ROCE.
  • Future polystyrene expansion from 100,000 to 150,000-170,000 tonnes under engineering study; capex expected around Rs. 150 crores.
  • ABS and SAN capacity expansion planned to add 100,000 tonnes in two phases; total capex around Rs. 500 crores, with some front-ended for quicker execution.
  • Thailand business currently has no major CAPEX planned; further investments will depend on business growth.
  • Working capital may increase if business grows, but no significant incremental capital investment is envisaged immediately.
  • Focus on capacity utilization optimization and operational efficiencies as key strategic priorities before further expansions.

💰 Fundraising & Capital Structure

- Currently, there is no major CAPEX planned for the Thailand business, and no significant incremental investment is envisaged at present. - If the Thailand business grows, additional working capital may be required, but the company plans to manage that carefully. - For expansions in India (ABS and polystyrene), estimated CAPEX is about Rs. 650 crores in total—Rs. 500 crores for ABS/SAN and Rs. 150 crores for polystyrene—planned in phases. - No explicit mention of new fundraising through debt or equity was made during the session. - The company intends to provide updates on any significant investment plans as they arise. Overall, no current plans for new fundraising through debt or equity have been disclosed.

📋 Order Book & Pipeline

The transcript does not explicitly mention current or expected orderbook or pending orders for Styrenix Performance Materials Limited. However, some related insights include: - The company is experiencing robust demand with sales volume growth of 14.3% YTD December 2024. - Capacity expansions planned: 50 KT ABS phase 1 followed by another 50 KT phase 2; polystyrene capacity increased from 65 KT to 100 KT with further expansion under study. - Validation and approvals for new applications in polystyrene are underway, expected to drive incremental volumes. - Thailand business has growth opportunities in automotive and household sectors, currently untapped. - Management expects volume growth in India business of around 15%-20%. - Synergies and product innovations in Thailand plant expected to contribute to revenue increases. - No explicit mention of orderbook size or pending orders was provided in the call.

Key Metrics

Frequently Asked Questions

What were Styrenix Performance Materials Ltd Q3 FY25 results?

India business volume growth guidance maintained at 15% to 20%, driven by capacity debottlenecking and expansions. Styrenix expects volume growth guidance of 15% to 20% for the India business, driven by capacity expansion and debottlenecking efforts. - Polystyrene capacity has expanded from 65,000 to 100,000 tonnes; further debottlenecking and capacity increase up to 150,000 tonnes are planned, expected to yield good ROCE despite lower polystyrene margins. - ABS expansion is planned in phases, adding 50,000 tonnes per phase; overall investment of approximately Rs.

What is Styrenix Performance Materials Ltd share price analysis?

Styrenix Performance Materials Ltd currently shows a neutral. The stock trades at a P/E of 14.0 with a market cap of ₹3,841 Cr. Investors should review the full earnings analysis for detailed insights.

Is Styrenix Performance Materials Ltd planning capital expenditure?

Polystyrene expansion: Debottlenecking increased capacity from 65,000 to 100,000 tonnes, adding about 35,000 tonnes volume at Rs.

Keep Styrenix Performance Materials Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.

Others in Chemicals & Petrochemicals this season

  • Tata Chemicals (Q3 FY25)

    . Key concall takeaways from Tata Chemicals Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Archean Chemical (Q3 FY25)

    . Key concall takeaways from Archean Chemical Industries Ltd's Q3 FY25 earnings call — and how it ranks against sector peers.

  • Aether Industries Ltd (Q3 FY25)

    Site 3+ and 3++ expansion underway with potential revenue of INR 300 crores combined. Key concall takeaways from Aether Industries Ltd's Q3 FY25 earnings call…

  • Tatva Chintan (Q3 FY25)

    Revenue potential could surpass INR 900 crores with existing and upcoming capacities by 2026. Key concall takeaways from Tatva Chintan Pharma Chem Ltd's Q3…